Latest filing published 05 Jul 2018 for Amicus Therapeutics, INC., €26k.
Filing timeline
BuySaleInsider track record
Kurt J. Andrews: trading record in brief
Kurt J. Andrews discloses dealings in Amicus Therapeutics, Inc. to SEC (Form 4). Between 15 June 2016 and 2 July 2018, the trades on record add up to 9 filings.
Every open-market trade on record is a sale: 3 sales worth €248k. Other entries cover 3 share grants and 3 option exercises. So far in 2018, the count stands at no purchases and 3 sales.
The record was last updated on 5 July 2018 with an option exercise (€26k) in Amicus Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kurt J. Andrews
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$6.136.2% of flowCommon StockSEC:0001209191-18-041616:0
- 5,000 shares@ US$15.6315.9% of flowCommon StockSEC:0001209191-18-041616:1
- 5,000 shares@ US$6.138.3% of flowCommon StockSEC:0001209191-18-023850:0
- 5,000 shares@ US$14.2719.4% of flowCommon StockSEC:0001209191-18-023850:1
- 5,732 shares0Common StockSEC:0001209191-18-002551:0
- 10,000 shares@ US$14.7241.0% of flowCommon StockSEC:0001209191-18-002063:0
- 30,487 shares0Common StockSEC:0001209191-17-002458:0
- 4,250 shares0Common StockSEC:0001209191-16-128377:0
8 of 8 declarations
